Stryker Q2 Sales Jump 9.4%, Adjusted EPS Up 17.9%; Narrows Full-Year Outlook After Cyberattack
SYK sits 16% above its 52-week low of $281.
Summary
Stryker reported Q2 2026 net sales of $6.59B (+9.4% YoY) and adjusted EPS of $3.69 (+17.9%), beating estimates. The company narrowed its full-year adjusted EPS guidance, citing the March 2026 cyberattack impact, and completed the AVS acquisition.
Key Events · Earnings and Guidance · SYK
-
Q2 Sales and Earnings Beat
Net sales rose 9.4% to $6.59B; adjusted EPS of $3.69 beat the $3.49 consensus, up 17.9% YoY.
-
Full-Year Guidance Narrowed
Stryker narrowed its full-year adjusted EPS outlook, explicitly linking the revision to the March 2026 cyberattack that disrupted operations.
-
Gross Margin Expansion
Gross margin improved to 68.3% from 63.8%, driven by a $158M reversal of 2025 tariffs and lower acquisition-related inventory charges.
-
AVS Acquisition Completed
Acquired Amplitude Vascular Systems for $435M net cash plus up to $400M in milestones, adding a next-gen intravascular lithotripsy platform.
Analysis · SYK · Industrial Applications And Services
A strong second quarter saw net sales climb 9.4% to $6.59 billion and adjusted earnings per share surge 17.9% to $3.69, handily beating consensus estimates. The company narrowed its full-year adjusted EPS guidance, explicitly attributing the revision to the lingering impact of a March 2026 cyberattack that disrupted operations. Gross margin expanded sharply, helped by a $158 million reversal of 2025 tariffs and lower acquisition-related inventory charges. The quarter also included the completion of the AVS acquisition for $435 million in cash plus up to $400 million in milestone payments, adding a next-generation intravascular lithotripsy platform to its peripheral vascular portfolio. While the results and guidance update are positive, the cyberattack's ongoing effect and the narrowed outlook introduce some uncertainty.
At the time of this filing, SYK was trading at $324.67 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $124.5B. The 52-week trading range was $281.00 to $401.99. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.